Skip to main content

Published locations for Two-fold higher risk for serious infections with tofacitinib vs bDMARD in older RA patients

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Two-fold higher risk for serious infections with tofacitinib vs bDMARD in older RA patients

User login

  • Reset your password
  • /content/two-fold-higher-risk-serious-infections-tofacitinib-vs-bdmard-older-ra-patients
  • /rheumatology/article/266755/rheumatoid-arthritis/two-fold-higher-risk-serious-infections-tofacitinib